Algorithme secures loan to fund diversification and growth
CRO Algorithme Pharma has announced plans to grow and diversify its business after securing support of Canadian financiers.
CRO Algorithme Pharma has announced plans to grow and diversify its business after securing support of Canadian financiers.
in-PharmaTechnologist presents a round up of current good manufacturing practice (cGMP) related warning letters sent by the FDA in the first quarter.
GSK is participating in a UK Government-backed innovative manufacturing initiative aimed at revitalising the sector.
The Southern Research Institute has partnered with the Biomedical Research Foundation of Northwest Louisiana (BRFNL) on non-invasive preclinical imaging.
update
US CRO Quintiles has postponed a financing plan it announced earlier this month, citing unfavourable global credit market conditions as the reason for the decision.
Switzerland-based Lonza has signed two new manufacturing deals with pharmaceutical firms that look set to improve capacity utilisation.
Gerresheimer has bought Brazilian pharmaceutical plastic packaging maker Vedat, citing rapid growth of the country’s drug market, particularly the generics segment, as the main driver for the acquisition.
Cyprotex posted double-digit revenue growth in 2010 and expects the upwards trend to continue as it benefits from its US acquisition.